Improving a Diabetes Patient's Day

Every day, almost 26 million Americans-more than 8% of the U.S. population- face a distinct health challenge that is the diabetes lifestyle.

With a constant need to control blood glucose levels with "exogenous" (externally produced) insulin in order to survive, diabetes patients often must administer their own specific dose several times per day. Even though insulin can save a diabetes patient from blindness, kidney damage, amputation or even death, self-care can present its own issues.

In an effort to help all people live healthy lives, BD has used 90 years of expertise in diabetes therapy, technology and research towards improving: 

Injection Site Practices: BD is supporting the advancement of specific injection practices-such as rotating injection sites-that can help prevent lipohypertrophy (an unhealthy growth of fat tissue below the skin) and make insulin absorption more effective.

BD's own research on skin thickness paved the way for the world's shortest pen needle. This needle length effectively delivers insulin to the subcutaneous tissue (the fat layer below the skin) while reducing the risk of injecting into the muscle, which may increase the risk of dangerously low blood sugar levels. 

The Patient Experience: BD's expertise in injection technology has resulted in PentaPoint™ Comfort, a patented needle tip design that increases patient comfort,2 and EasyFlow™ Technology, a needle configuration specifically engineered with better flow. These advances mean less force and time to deliver a dose while making injections more comfortable for patients.

Thought Leadership for Better Care: In 2009, BD sponsored the TITAN Conference, where 127 key opinion leaders on diabetes gathered to develop the current guidelines for injection best practices.

Around the world, "FIT" (Forum for Injection Technique) Councils feature leading Diabetes Nurse Educators who advise on country-specific guidelines for proper insulin injection usage.

For more on BD's focus on diabetes care, visit

<<   Back to Showcase Archive

  1. American Diabetes Association, Statistics;
  2. Hirsch LJ, et al. Journal of Diabetes Science and Technology 2012;6(2):328-35.
  3. Aronson R, et al. Clin Ther 2013;35:923-33
  4. Davidson JA, et al. Diabetes Metabolism 2010;36:Suppl 2:S2.